Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

With this longer lifespan, calcific aortic stenosis (AS) was identified as an emerging critical risk factor for cardiac death in older patients. However, HGPS patient-device size mismatch, pervasive peripheral arterial disease, skin and bone abnormalities, and lifelong failure to thrive present unique challenges to intervention.

Stenosis 52

Stenosis Aortic Peripheral Arterial Disease TAVR 52

DAIC

MAY 1, 2024

Featuring numerous abstracts with fresh insights into health disparities, efficacy data for TAVR, and innovative strategies for PAD, we eagerly anticipate the convergence of professionals from diverse specialties. About 276,000 patients have undergone a TAVR procedure in the United States. PAD contributes to 400 amputations each day.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105